Zoledronic acid effectively prevents aromatase inhibitor- associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-fast study 36-month follow-up results

Adam M. Brufsky, Linda D. Bosserman, Richard R. Caradonna, Barbara B. Haley, C. Michael Jones, Halle C.F. Moore, Lixian Jin, Ghulam M. Warsi, Solveig G. Ericson, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

166 Scopus citations

Fingerprint

Dive into the research topics of 'Zoledronic acid effectively prevents aromatase inhibitor- associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-fast study 36-month follow-up results'. Together they form a unique fingerprint.

Medicine & Life Sciences